Community pharmacist-led interventions and their impact on patients’ medication adherence and other health outcomes: a systematic review

Aleksandra Milosavljevic; Trudi Aspden; Jeff Harrison

doi:10.1111/ijpp.12462

journal article Jun 21, 2018

Community pharmacist-led interventions and their impact on patients’ medication adherence and other health outcomes: a systematic review

Aleksandra Milosavljevic

Trudi Aspden Jeff Harrison

International Journal of Pharmacy Practice Vol. 26 No. 5 pp. 387-397 · Oxford University Press (OUP)

View at Publisher Save 10.1111/ijpp.12462

Abstract

Abstract

Introduction
Medication adherence can be defined as the extent to which one’s medication-taking behaviour follows that mutually agreed upon by the prescribing physician. Optimal medication adherence is often deemed crucial for the success of a patient's treatment, as suboptimal adherence may lead to treatment failure and unnecessary medical expenditure. Increasing evidence has highlighted the positive contribution community pharmacist-led interventions can have on improving patients’ adherence and health outcomes.

Objectives
To provide an overview of the published literature on community pharmacist-led interventions and their effectiveness in improving patients’ adherence and health outcomes.

Methods
A search strategy was developed, aiming to retrieve published reports of community pharmacy interventions worldwide. Medline, EMBASE, International Pharmaceutical Abstracts, Google Scholar and ProQuest Dissertations and Theses databases were searched. Articles meeting the inclusion criteria were collated, relevant data extracted, and a risk of bias assessment undertaken.

Key Findings
Twenty-two studies were included in the analysis, and their outcomes were reported in 26 peer-reviewed journal articles. Community pharmacist-led interventions have been shown to improve patients’ adherence and contribute to better blood pressure control, cholesterol management, chronic obstructive pulmonary disease and asthma control. Studies in this review, however, did not report statistically significant effects of interventions on diabetes or depression control.

Conclusion
Community pharmacist-led interventions have been shown to contribute to improved adherence and better disease control. Future research should attempt to better understand which particular intervention components make the greatest contribution towards improving adherence and health outcomes, for patients with different medical conditions.

Topics

No keywords indexed for this article. Browse by subject →

References

54

[1]

Sabaté (2003)

[2]

Andrade "Methods for evaluation of medication adherence and persistence using automated databases" Pharmacoepidemiol Drug Saf (2006) 10.1002/pds.1230

[3]

Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection

David L. Paterson, Susan Swindells, Jeffrey Mohr et al.

Annals of Internal Medicine 2000 10.7326/0003-4819-133-1-200007040-00004

[4]

Medication Adherence Leads To Lower Health Care Use And Costs Despite Increased Drug Spending

M. Christopher Roebuck, Joshua N. Liberman, Marin Gemmill-Toyama et al.

Health Affairs 2011 10.1377/hlthaff.2009.1087

[5]

Acri "Textbook of Pharmacoepidemiology" (2013)

[6]

Chisholm-Burns "US pharmacists’ effect as team members on patient care: systematic review and meta-analyses" Med Care (2010) 10.1097/mlr.0b013e3181e57962

[7]

Hepler "Opportunities and responsibilities in pharmaceutical care" Am J Hosp Pharm (1990)

[8]

The Effect of Community Pharmacy–Based Interventions on Patient Health Outcomes

Susan J. Blalock, Andrew W. Roberts, Julie C. Lauffenburger et al.

Medical Care Research and Review 2013 10.1177/1077558712459215

[9]

Eussen "A pharmaceutical care program to improve adherence to statin therapy: a randomized controlled trial" Ann Pharmacother (2010) 10.1345/aph.1p281

[10]

Saini "Development, implementation, and evaluation of a community pharmacy-based asthma care model" Ann Pharmacother (2004) 10.1345/aph.1e045

[11]

Higgins

[12]

Taylor "Implementing pharmaceutical care in an inner city pharmacy: hypertension management and elderly African Americans" J Aging Pharmacother (2003) 10.3109/j397v13n01_08

[13]

Tommelein "Effectiveness of pharmaceutical care for patients with chronic obstructive pulmonary disease (PHARMACOP): a randomized controlled trial" Br J Clin Pharmacol (2013) 10.1111/bcp.12242

[14]

Bosmans "Cost effectiveness of a pharmacy-based coaching programme to improve adherence to antidepressants" Pharmacoeconomics (2007) 10.2165/00019053-200725010-00004

[15]

Brook "Impact of coaching by community pharmacists on drug attitude of depressive primary care patients and acceptability to patients: a randomized controlled trial" Eur Neuropsychopharmacol (2003) 10.1016/s0924-977x(02)00074-3

[16]

Svarstad "Improving refill adherence and hypertension control in black patients: Wisconsin TEAM trial" J Am Pharm Assoc (2013) 10.1331/japha.2013.12246

[17]

Rubio-Valera "Cost-effectiveness of a community pharmacist intervention in patients with depression: a randomized controlled trial (PRODEFAR study)" PLoS One (2013) 10.1371/journal.pone.0070588

[18]

Rubio-Valera "Evaluation of a pharmacist intervention on patients initiating pharmacological treatment for depression: a randomized controlled superiority trial" Eur Neuropsychopharmacol (2013) 10.1016/j.euroneuro.2012.11.006

[19]

Rickles "Pharmacist telemonitoring of antidepressant use: effects on pharmacist-patient collaboration" J Am Pharm Assoc (2003) (2005) 10.1331/1544345054003732

[20]

Robinson "Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice" Ann Pharmacother (2010) 10.1345/aph.1l289

[21]

Planas "Evaluation of a hypertension medication therapy management program in patients with diabetes" J Am Pharm Assoc (2009) 10.1331/japha.2009.08164

[22]

Bouvy "Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study" J Card Fail (2003) 10.1054/s1071-9164(03)00130-1

[23]

McKenney "The effect of clinical pharmacy services on patients with essential hypertension" Circulation (1973) 10.1161/01.cir.48.5.1104

[24]

Ottenbros "Pharmacist-led intervention study to improve drug therapy in asthma and COPD patients" Int J Clin Pharm (2014) 10.1007/s11096-013-9887-4

[25]

Lai "Community pharmacy-based hypertension disease-management program in a Latino/Hispanic-American population" Consult Pharm (2007) 10.4140/tcp.n.2007.411

[26]

Spence "Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease" J Manag Care Spec Pharm (2014)

[27]

Aslani "A community pharmacist delivered adherence support service for dyslipidaemia" Eur J Public Health (2010) 10.1093/eurpub/ckq118

[28]

Morisky "Predictive Validity of A Medication Adherence Measure in an Outpatient Setting" Journal of Clinical Hypertension (2008) 10.1111/j.1751-7176.2008.07572.x

[29]

Jahangard-Rafsanjani "Effect of a community pharmacist-delivered diabetes support program for patients receiving specialty medical care: a randomized controlled trial" Diabetes Educ (2015) 10.1177/0145721714559132

[30]

Armour "Pharmacy asthma care program (PACP) improves outcomes for patients in the community" Thorax (2007) 10.1136/thx.2006.064709

[31]

Zillich "Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study)" J Gen Intern Med (2005) 10.1111/j.1525-1497.2005.0226.x

[32]

Aguiar "Pharmaceutical care program for elderly patients with uncontrolled hypertension" J Am Pharm Assoc (2003) (2012) 10.1331/japha.2012.11015

[33]

Mehuys "Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial" J Clin Pharm Ther (2011) 10.1111/j.1365-2710.2010.01218.x

[34]

Mehuys "Effectiveness of pharmacist intervention for asthma control improvement" Eur Respir J (2008) 10.1183/09031936.00112007

[35]

Sturgess "Community pharmacy based provision of pharmaceutical care to older patients" Pharm World Sci (2003) 10.1023/a:1025860402256

[36]

Stewart "A multifaceted pharmacist intervention to improve antihypertensive adherence: a cluster-randomized, controlled trial (HAPPy trial)" J Clin Pharm Ther (2014) 10.1111/jcpt.12185

[37]

Stewart "Challenges in measuring medication adherence: experiences from a controlled trial" Int J Clin Pharm (2014) 10.1007/s11096-013-9877-6

[38]

Lau "Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial" BMC Health Serv Res (2010) 10.1186/1472-6963-10-34

[39]

Blenkinsopp "Extended adherence support by community pharmacists for patients with hypertension: a randomised controlled trial" Int J Pharm Pract (2000) 10.1111/j.2042-7174.2000.tb01002.x

[40]

Van Wijk "Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review" Ann Pharmacother (2005) 10.1345/aph.1e027

[41]

Armour "Implementation and evaluation of Australian pharmacists’ diabetes care services" J Am Pharm Assoc (2004) 10.1331/1544345041475625

[42]

Cranor "The Asheville project: long-term clinical and economic outcomes of a community pharmacy diabetes care program" J Am Pharm Assoc (Wash) (2003) 10.1331/108658003321480713

[43]

Doucette "Community pharmacist-provided extended diabetes care" Ann Pharmacother (2009) 10.1345/aph.1l605

[44]

Krass "The pharmacy diabetes care program: assessment of a community pharmacy diabetes service model in Australia" Diabetic Med (2007) 10.1111/j.1464-5491.2007.02143.x

[45]

Sookaneknun "Pharmacist involvement in primary care improves hypertensive patient clinical outcomes" Ann Pharmacother (2004) 10.1345/aph.1d605

[46]

Chan "Patient, physician, and payment predictors of statin adherence" Med Care (2010) 10.1097/mlr.0b013e3181c132ad

[47]

Zedler "Does packaging with a calendar feature improve adherence to self-administered medication for long-term use? A systematic review" Clin Ther (2011) 10.1016/j.clinthera.2011.02.003

[48]

Thoopputra "Interventions in chronic disease management: a review of the literature on the role of community pharmacists" Am J Pharm Health Res (2015)

[49]

Raynor "Patient compliance: the pharmacist's role" Int J Pharm Pract (1992) 10.1111/j.2042-7174.1992.tb00554.x

[50]

Vrijens "Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories" BMJ (2008) 10.1136/bmj.39553.670231.25

Showing 50 of 54 references

Cited By

218

COVID-19 pandemic: the role of community-based pharmacy practice in health equity

Youssef M. Roman · 2022

International Journal of Clinical P...

Metrics

218

Citations

54

References

Details

Published: Jun 21, 2018
Vol/Issue: 26(5)
Pages: 387-397
License: View

Authors

A

Aleksandra Milosavljevic

School of Pharmacy, The University of Auckland, Auckland, New Zealand

T

Trudi Aspden

School of Pharmacy, The University of Auckland, Auckland, New Zealand

J

Jeff Harrison

School of Pharmacy, The University of Auckland, Auckland, New Zealand

Cite This Article

Aleksandra Milosavljevic, Trudi Aspden, Jeff Harrison (2018). Community pharmacist-led interventions and their impact on patients’ medication adherence and other health outcomes: a systematic review. International Journal of Pharmacy Practice, 26(5), 387-397. https://doi.org/10.1111/ijpp.12462

Community pharmacist-led interventions and their impact on patients’ medication adherence and other health outcomes: a systematic review

You May Also Like